Copyright
        ©2006 Baishideng Publishing Group Co.
    
    
        World J Gastroenterol. Apr 21, 2006; 12(15): 2369-2374
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2369
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2369
            Table 1 Primer sequences for PCR amplification
        
    | mRNA | Primer sequence | Length (bp) | 
| Collagen I | Sense 5' CGA CTA AGT TGG AGG GAA CGG TC 3' | 182 | 
| Antisense 5' TGG CAT GTT GCT AGG CAC GAC 3' | ||
| TIMP-1 | Sense 5' TCC CTT GCA AAC TGG AGA GT 3' | 140 | 
| Antisense 5' GTC ATC GAG ACC CCA AGG TA 3' | ||
| TGF-b1 | Sense 5' TAT AGC AAC AAT TCC TGC CG 3' | 162 | 
| Antisense 5' TGC TGT CAC AGG AGC AGTG 3' | ||
| GAPDH | Sense 5' CTT CAT TGA CCT CAA CTA CAT GGT CTA 3' | 99 | 
| Antisense 5' GATG ACA AGC TTC CCA TTC TCA G 3' | 
            Table 2 Effect of FMAC on plasma albumin concentration and prothrombin time in CCl4-treated rats
        
    | Group | Dose | Albumin | Prothrombin time | 
| (g/kg per d) | (g/L) | (sec) | |
| Control | – | 36.0 ± 1.3 | 17.7 ± 0.9 | 
| CCl4 + H2O | – | 22.7±1.0b | 36.7 ± 7.2b | 
| CCl4 + FMAC | 0.5 | 23.1 ± 5.1 | 28.5 ± 9.9 | 
| 1 | 30.7±2.5a | 25.1 ± 10.2a | 
            Table 3 Effect of FMAC on spleen weight, hepatic malondialdehyde and hydroxyproline contents in CCl4-treated rats
        
    | Group | Dose | Spleen | Malondialdehyde | Hydroxyproline | 
| (g/kg per d) | (g) | (μmol/g protein) | (μg/g tissue) | |
| Control | – | 1.1 ± 0.1 | 1.9 ± 0.1 | 645.0 ± 64.5 | 
| CCl4 + H2O | – | 2.7 ± 0.1d | 3.9 ± 0.1d | 1730.7 ± 258.0d | 
| CCl4 + FMAC | 0.5 | 2.8 ± 0.2 | 2.7 ± 0.1 | 1741.5 ± 257.1 | 
| 1 | 2.4 ± 0.2a | 2.4 ± 0.6b | 1311.5 ± 238.8b | 
            Table 4 Effect of FMAC on hepatic mRNA expressions of collagen I, TIMP-1 and TGF-β1 in CCl4-treated rats
        
    | Group | Dose | Collagen I:GAPDH | TGF-β1:GAPDH | TIMP-1:GAPDH | 
| (g/kg per d) | ratio | ratio | ratio | |
| Control | – | 0.68 ± 0.55 | 0.38 ± 0.18 | 0.14 ± 0.08 | 
| CCl4 + H2O | – | 5.63 ± 2.08b | 38.03 ± 11.9b | 1.70 ± 0.82b | 
| CCl4 + FMAC | 0.5 | 3.94 ± 1.18 | 28.90 ± 7.22 | 0.58 ± 0.02 | 
| 1 | 1.78 ± 0.48d | 4.26 ± 2.17d | 0.34 ± 0.02d | 
            Table 5 Effect of FMAC on CCl4-induced liver fibrosis in rats
        
    | Group | Dose | Score of hepatic fibrosis | Average | ||||
| (g/kg per d) | 0 | 1 | 2 | 3 | 4 | ||
| Control | – | 10 | 0 | 0 | 0 | 0 | 0 | 
| CCl4 + H2O | – | 0 | 0 | 3 | 6 | 1 | 2.8 ± 0.6 | 
| CCl4 + FMAC | 0.5 | 0 | 1 | 3 | 5 | 1 | 2.7 ± 0.8 | 
| 1.0 | 0 | 4 | 5 | 1 | 0 | 1.7 ± 0.7b | |
- Citation: Lin WC, Kuo SC, Lin WL, Fang HL, Wang BC. Filtrate of fermented mycelia from Antrodia camphorata reduces liver fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol 2006; 12(15): 2369-2374
- URL: https://www.wjgnet.com/1007-9327/full/v12/i15/2369.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i15.2369

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        